3165: Coronavirus Essential | CoWIN app is mandatory for vaccination, says health ministry; Delhi extends COVID guidelines for UK returnees

3164: Corporate Buzz | Why India Inc may not get a tax cut this Budget; minimum wage rule puts H1b visas out of reach; how vaccines could get cheaper

3163: The Market Podcast | Zerodha's Nikhil Kamath has these 3 expectations from FM in Budget 2021

3162: Macro Minutes | Budget 2021: HSBC Chief Economist Prajul Bhandari pins hopes on higher tax buoyancy, privatization in FY22

3161: Coronavirus Essential | PM Modi to launch COVID-19 vaccination drive on January 16; 3 lakh healthcare workers to receive shots on the first day

3160: D-Street Talk | Indian Markets at record highs! What should investors do?

3159: Budget 2021 | How govt can help healthcare sector become self-reliant post-COVID

3158: Hot Stocks | Power Grid, Federal Bank, Aditya Birla Fashion can give up to 10% return in short-term

3157: Coronavirus Essential | India sees lowest active caseload after almost 200 days; Delhi govt to provide free vaccines if Centre does not, says Arvind Kejriwal

3156: Budget 2021 | Auto Industry hopes to hear more on Make in India and Electric Vehicles

3155: Future Wise | How women can restart their second career in the technology industry

3154: Hot Stocks | Can bet on Sun TV, Hero MotoCorp, Tata Coffee for short-term

3153: Coronavirus Essential | First batches of Covishield shots distributed across India; Serum Institute to sell vaccines at Rs 1,000 per dose in private markets

3152: Simply Save | Budget 2021: Choosing between the old and the new tax regimes

3151: Hot Stocks | PNC Infratech, Maithan Alloys, Emami can give up to 14% return in short-term

3150: Coronavirus Essential | India all set for the vaccination drive; PM CARES fund to bear vaccine cost for 3 crore frontline workers

3149: Macro Minutes | High probability of successful vaccine rollout expected in current quarter: Shubhada Rao

3148: For Monday: Hot Stocks | Here's why Concor and BHEL are short-term bets

3147: Corporate Buzz | Why the Bharat Biotech vs Serum Institute war is far from over; Mahindra lags in the auto race; Will India's vaccine drive be efficient?

3146: Coronavirus Essential | States conduct second dry run for vaccinations; Pfizer vaccine appears effective against new COVID-19 variants, says study